PointState Capital’s Evolus EOLS Stock Holding History

PointState Capital’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-660,000	Closed	-$12.3M	–	106
2018 Q3	$12.3M	Buy	+660,000	New	+$14.3M	0.16%	72

Other funds holding EOLS

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

TCM

Tygh Capital Management Portland, Oregon $782M AUM 39.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PointState Capital's EOLS Position: Q4 2018 in Review

PointState Capital sold out of Evolus (EOLS) in Q4 2018, closing a stake of 660,000 shares — an estimated $12.3M sold.

PointState Capital first reported a position in EOLS in Q3 2018 and held it in 1 quarter. The position peaked at $12.3M in Q3 2018. 76 funds tracked by Wall St. Rank hold EOLS as of Q4 2018.

PointState Capital reported no remaining Evolus position as of Q4 2018 after selling out during the quarter.
PointState Capital sold 660,000 Evolus shares in Q4 2018, an estimated $12.3M.
PointState Capital first reported a position in Evolus in Q3 2018 and held it in 1 quarter.
PointState Capital's Evolus position peaked at $12.3M in Q3 2018.
76 funds tracked by Wall St. Rank held Evolus as of Q4 2018.

Based on PointState Capital's 13F filing for Q4 2018, filed 14 Feb 2019.